DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and its 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and its 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and its 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to a total of 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and their 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to a total of 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and their 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to a total of 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and their 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.